Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
Part of paid clinical trials in North Little Rock, Arkansas.
- Sponsor
- Altimmune, Inc.
- Study ID
- NCT07795164
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Pemvidutide — DRUGPemvidutide SC Injection
- Placebo — OTHERPlacebo SC Injection
Study Details
Phase 3, multicenter, multinational, 2-cohort, randomized, double-blind, placebo controlled, parallel-group pivotal study to evaluate the efficacy, safety, and clinical outcomes of pemvidutide treatment in subjects with noncirrhotic (F2 or F3) metabolic dysfunction-associated steatohepatitis (MASH). Participants will be assigned either to Cohort 1 based on screening histologic (liver biopsy) criteria or to Cohort 2 based on non-invasive test criteria.
Key Dates
- First listed
- Aug 31, 2026
- Start date
- Jul 30, 2026
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2032
Study Design
- Enrollment
- 1,800 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Pemvidutide 1.8 mg
- Experimental: Pemvidutide 2.4 mg
- Placebo Comparator: Placebo
Primary Outcome Measure
Clinical Outcome Event [ Time Frame: Baseline through end of study (approximately Month 60) ]
Central Contacts
- Shaheen Tomah, MD240-654-1450
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Altimmune Clinical Study Site | North Little Rock | Arkansas | 72117 | - |
| Altimmune Clinical Study Site | Fountain Valley | California | 92708 | - |
| Altimmune Clinical Study Site | Fresno | California | 93720 | - |
| Altimmune Clinical Study Site | Gardena | California | 90247 | - |
| Altimmune Clinical Study Site | Long Beach | California | 90815 | - |
| Altimmune Clinical Study Site | Miami | Florida | 33173 | - |
| Altimmune Clinical Study Site | Ocala | Florida | 34471 | - |
| Altimmune Clinical Study Site | Springboro | Ohio | 45066 | - |
| Altimmune Clinical Study Site | Westlake | Ohio | 44145 | - |
Find similar trials in North Little Rock, AR
Related Studies
- A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This ConditionPHASE2 · Recruiting · Regeneron Pharmaceuticals · Chandler, Arizona
- Fibrosis Lessens After Metabolic SurgeryPHASE4 · Recruiting · The Cleveland Clinic · Phoenix, Arizona
- A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)PHASE1/PHASE2 · Not Yet Recruiting · Kriya Therapeutics, Inc. · Chandler, Arizona
- Nutrition Intervention Combined With Resmetirom for MASHPHASE4 · Not Yet Recruiting · City University of New York · New York, New York